Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment. (Q40409098)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28012257%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

title

Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28012257%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

main subject

hepatocellular carcinoma

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28012257%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

author name string

Jung Hee Kim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28012257%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Wonseok Kang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28012257%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Geum-Youn Gwak

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28012257%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Yong-Han Paik

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28012257%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Moon Seok Choi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28012257%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Joon Hyeok Lee

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28012257%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Kwang Cheol Koh

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28012257%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Seung Woon Paik

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28012257%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

language of work or name

English

0 references

publication date

24 December 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28012257%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28012257%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28012257%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

page(s)

335-343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28012257%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28012257%20AND%20SRC:MED&resulttype=core&format=json

KASL clinical practice guidelines: management of chronic hepatitis B

1 April 2020

cites work

1 reference

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.

21 January 2018

1 reference

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

21 January 2018

1 reference

Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B.

21 January 2018

1 reference

Lamivudine for patients with chronic hepatitis B and advanced liver disease

21 January 2018

1 reference

Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis

21 January 2018

1 reference

Does hepatitis B treatment reduce the incidence of hepatocellular carcinoma?

21 January 2018

1 reference

Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B.

21 January 2018

1 reference

KASL Clinical Practice Guidelines: Management of chronic hepatitis B.

21 January 2018

1 reference

Telbivudine versus lamivudine in patients with chronic hepatitis B

21 January 2018

1 reference

AASLD guidelines for treatment of chronic hepatitis B.

21 January 2018

1 reference

Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir

21 January 2018

1 reference

Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir.

21 January 2018

1 reference

Tenofovir monotherapy and tenofovir plus entecavir combination as rescue therapy for entecavir partial responders.

21 January 2018

1 reference

Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma

21 January 2018

1 reference

Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection

21 January 2018

1 reference

Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load

21 January 2018

1 reference

Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis

21 January 2018

1 reference

Efficacy of entecavir treatment for up to 96 weeks in nucleoside-naive HBeAg-positive chronic hepatitis B patients with high viral load

21 January 2018

1 reference

Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load

21 January 2018

1 reference

Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.

21 January 2018

1 reference

Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).

21 January 2018

1 reference

Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.

21 January 2018

1 reference

Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea

21 January 2018

1 reference

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response

21 January 2018

1 reference

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.28916

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28012257%20AND%20SRC:MED&resulttype=core&format=json

release_2imeuiaudnfntozfpaahjlu4vm

1 April 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2imeuiaudnfntozfpaahjlu4vm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference